2.015
price down icon1.71%   -0.035
 
loading

Finanzdaten der Moleculin Biotech Inc-Aktie (MBRX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.25%
5.906
5.72 5.943 6.643 7.135
Operating Income/Loss
3.25%
-5.906
-5.72 -5.943 -6.643 -7.135
Income/Loss From Continuing Operations Before Tax
42.62%
-25.40
-17.81 -5.904 -1.882 -10.59
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
42.62%
-25.40
-17.81 -5.904 -1.882 -10.59
Net Income/Loss
42.62%
-25.40
-17.81 -5.904 -1.882 -10.59
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
140.26%
37.30
15.53 9.3438 0.5322 3.7143
Basic Earnings Per Share
40.87%
-0.68
-1.15 -0.63 0.51 -2.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):